GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide IARC Cancer Base, No. 5, Version 2.0. Lyon, France: IARC Press; 2004.
Risk of cancer in migrants and their descendants in Israel: II. Carcinomas and germ-cell tumours. Int J Cancer 1997 Mar;70(6):654-660.
Prevalence and relevance of EBV latency in nasopharyngeal carcinoma in Israel. J Clin Pathol 2004 Mar;57(3):290-293.
Second report of the National Cancer Registry: cancer incidence in Malaysia, National Cancer Registry. Kuala Lumpur: Ministry of Health of Malaysia; 2003.
Nasopharyngeal carcinoma: the next challenges. Eur J Cancer 2010 Jul;46(11):1967-1978.
The efficacy of fiberoptic endoscopic examination and biopsy in the detection of early nasopharyngeal carcinoma. Cancer 1991 June;67(12):3127-3130.
Tumors of the nasopharynx: Introduction. In: Barnes L, Eveson JW, Reichart P, Sidransky D, editors. Pathology and genetics of head and neck tumours (World Health Organization Classification of Tumours). Lyon, France: IARC Press; 2005. p. 82-84.
Review of nasopharyngeal carcinoma. Ear Nose Throat J 2006 Mar;85(3):168-170, 172-173, 184.
Nasopharyngeal carcinoma spreading along the eustachian tube: The imaging appearance. J Chin Med Assoc 2004 Apr;67(4):200-203.
[A case with nasopharyngeal carcinoma extending into the cavernous sinus] [Article in Japanese]. No Shinkei Geka 1997 Oct;25(10):939-942.
Involvement of the cavernous sinus by malignant (extracranial) tumour: palliation in six cases without surgery. J Craniomaxillofac Surg 2000 Jun;28(3):161-164.
[Evaluation of MRI in nasopharyngeal carcinoma with cavernous sinus infiltration] [Article in Chinese] Zhonghua Zhong Liu Za Zhi 2006 Jul;28(7):530-532.
Nasopharyngeal carcinoma with intracranial spread: CT and MR characteristics. J Comput Assist Tomogr 1996 Jul-Aug;20(4):563-569.
Improved outcome secondary to concurrent chemoradiotherapy for advanced carcinoma of the nasopharynx: preliminary corroboration of the intergroup experience. Int J Radiat Oncol Biol Phys 2000 Jul;47(4):861-866.